Occamy Bioscience Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 0.34 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.10 M
- Revenue Growth 52.43%
- Profit Growth 39.84%
- Ebitda 2.79%
- Net Worth -18.39%
- Total Assets 27.99%
About Occamy Bioscience
Occamy Bioscience Private Limited (OBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 28 August 2018 (Six years and five months 27 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.34 M.
The company currently has active open charges totaling ₹4.10 M.
Milind Niphadkar and Saloni Godbole serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2018PTC313143
- Company No.
313143
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Occamy Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saloni Godbole  | Director | 28-Aug-2018 | Current |
| Milind Niphadkar | Director | 28-Aug-2018 | Current |
Financial Performance of Occamy Bioscience.
Occamy Bioscience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.43% increase. The company also saw a substantial improvement in profitability, with a 39.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Occamy Bioscience?
Unlock access to Occamy Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Matra Supplements And Additives Private LimitedMilind Niphadkar is a mutual person
Charges (Loans)
₹4.10 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2020 | State Bank Of India | ₹4.10 M | Open |
How Many Employees Work at Occamy Bioscience?
Unlock and access historical data on people associated with Occamy Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Occamy Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Occamy Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.